Skip Navigation
Find a Doctor
 
 
 
 

 

Photo of Dr. Alan Partin

Alan Wayne Partin, MD

David Hall McConnell Professor and Director of Urology
Professor of Urology

See Research on Pubmed

Male
Appointment Phone

410-955-6100

Main Location

Johns Hopkins Outpatient Center

View All Locations
Out-of-State & International Patients +
Out of State Patients

Call 410-464-6641 (8a.m. to 6p.m., EST, Mon-Fri)

Learn more about our out-of-state patient services »

International Patients

Call +1-410-502-0773 (7a.m. to 6p.m., EST, Mon-Fri)

Learn more about our international patient services »

Titles

  • David Hall McConnell Professor and Director of Urology
  • Urologist -in-Chief, Department of Urology, Oncology
  • Professor of Urology
  • Professor of Oncology
  • Professor of Pathology

Centers & Institutes

  • James Buchanan Brady Urological Institute
  • Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins

Expertise

Benign Prostatic Hyperplasia, Prostate Cancer, Urology, Urology / Urologic Surgery, Urology, Adult

Research Interests

Bio-Markers for Prostate Disease; Benign prostatic hyperplasia; Prostate cancer; Urology; Urologic surgery

Biography

Dr. Alan Partin is a professor of urology, oncology and pathology at the Johns Hopkins School of Medicine. His areas of clinical expertise include prognosis prediction for men with prostate cancer and treatment of benign prostatic hyperplasia with an emphasis on minimally invasive techniques. Dr. Partin serves as the David Hall McConnell Director of Urology and Urologist-in-Chief for the Department of Urology and Oncology.

Dr. Partin's research focuses on development and testing of new and existing methods for predicting the aggressiveness of prostate cancers. His laboratories have investigated many new serum tests, some of which are soon to become available for the diagnosis of prostate cancer as well as basics science investigation of new proteins, which may help in detection, and staging of prostate cancer.

Dr. Partin is credited with creating a set of tables widely known as the Partin Tables. These tables are based on accumulated data from hundreds of patients who had been treated for prostate cancer and are used to predict pathologic stage (the cancer stage as determined by a pathologist after surgery) from clinical (pre-surgery) variables. The accurate prediction of pathologic stage can help physicians and patients choose the most appropriate treatments.

He received his undergraduate degree in chemistry at the University of Mississippi. He earned his M.D. and Ph.D. in pharmacology and molecular systems from Johns Hopkins University School of Medicine. Dr. Partin also completed his residency in urology and surgery at The Johns Hopkins Hospital.

Dr. Partin has served on many advisory boards including the Sidney Kimmel Comprehensive Cancer Center Advisory Council and the NCI Early Diagnostic Research Network Executive Committee. He has been recognized with the Ambrose Monell Research Award, David Koch Prostate Cancer Research Award and the 2002 AUA/ACMI Gold Cystoscope Award, among others. He is a member of the American Medical Association and the American Urological Association.

Languages

  • English

Memberships

American Medical Students Association

Society for Basic Urologic Research

American Medical Association

American Urological Association

American Cancer Society

Alpha Lambda Delta

Phi Eta Sigma

Alpha Epsilon Delta

Phi Kappa Phi

Lambda Delta

Mortar Board

Omicron Delta Kappa

Clinical Trial Keywords

  • Prostate Cancer

Additional Resources

Additional Resources +
  • Education +

    Training

    • Johns Hopkins University School of Medicine (Baltimore MD) (1989)

    Residencies

    • Johns Hopkins University School of Medicine / Urology (Baltimore MD) (1995)
    • Johns Hopkins University School of Medicine / Surgery (Baltimore MD) (1991)

    Certifications

    • American Board of Urology / Urology (2007)
  • Research & Publications +

    Research Summary

    Dr. Partin’s laboratories are focused on development and testing of new and existing methods for predicting the aggressiveness of prostate cancers so that rational treatment decisions can be made by both patients and physicians. The laboratories have investigated many new serum tests, some of which are soon to become available for the diagnosis of prostate cancer as well as basics science investigation of new proteins, which may help in detection, and staging of prostate cancer.

    Selected Publications View all on PubMed

    1. Sundi D, Wang V, Pierorazio PM, Han M, Partin AW, Tran PT, Ross AE, Bivalacqua TJ. “Identification of men with the highest risk of early disease recurrence after radical prostatectomy.” Prostate. 2014 Jan 22. doi: 10.1002/pros.22780.
    2. Ball MW, Mullins JK, Epstein JI, Partin AW, Walsh PC. “Re: detailed analysis of patients with metastasis to the prostatic anterior fat pad lymph nodes: a multi-institutional study: I. Y. Kim, p. K. Modi, e. Sadimin, y.-S. Ha, j. H. Kim, d. Skarecky, d. Y. Cha, C. O. Wambi, y.-C. Ou, B. Yuh, s. Park, e. Llukani, d. M. Albala, T. Wilson, T. Ahlering, k. Badani, h. Ahn, d. I. Lee, m. May, w.-J. Kim and d. H. Lee j urol 2013;190:527-534.” J Urol. 2014 Feb;191(2):559-61. doi: 10.1016/j.juro.2013.07.103.
    3. Sundi D, Wang VM, Pierorazio PM, Han M, Bivalacqua TJ, Ball MW, Antonarakis ES, Partin AW, Schaeffer EM, Ross AE. “Very-high-risk localized prostate cancer: definition and outcomes.” Prostate Cancer Prostatic Dis. 2014 Mar;17(1):57-63. doi: 10.1038/pcan.2013.46.
    4. Inoue LY, Trock BJ, Partin AW, Carter HB, Etzioni R. “Modeling grade progression in an active surveillance study.” Stat Med. 2014 Mar 15;33(6):930-9. doi: 10.1002/sim.6003.
    5. Loeb S, Assimos D, Chancellor MB, Nickel JC, Brawer MK, Kern AJ, Partin AW. “Best of the 2013 AUA Annual Meeting: Highlights From the 2013 American Urological Association Meeting, May 4-8, 2013, San Diego, CA.” Rev Urol. 2013;15(2):72-81. Review.
  • Academic Affiliations & Courses +
  • Activities & Honors +

    Honors

    Ambrose Monell Research Award

    David Koch Prostate Cancer Research Award

    Clinical Society of Genitourinary Surgeons, 2005

    American Association of Genitourinary Surgeons, 2002

    AUA/ACMI Gold Cystoscope Award, 2002

    Pfizer Scholars in Urology Award, 1996

    American Urological Association, Clinical Research Third Prize, 1995

    Zeneca Resident Writers Award 2nd Prize, 1995

    American Urological Association, Clinical Research Third Prize, 1994

    Mid-Atlantic AUA Clinical Research Award, First Prize, 1994

    Johns Hopkins Young Investigators Award, First Prize, Clinical, 1993

    Mid-Atlantic AUA Clinical Research Essay, Second Prize, 1993

    Mid-Atlantic AUA Clinical Research Essay, First Prize, 1992

    Medical Scientist Training Program (MSTP) award, 1984

    University of Mississippi summa cum laude.

    Graduated number one in class University of Mississippi.

    College Football Academic All-S.E.C. and All-American, 1983

    U. of Miss. Taylor Medal for Academic Excellence,1982, 1983

    State of Mississippi representative to National Rhodes Scholar Selection, 1983

    High School Football second team All-American, 1979

    High School Football Academic All-American First Team, 1979

    National Key Club Lieutenant Governor of the Year, 1979

    Grenada High School Valedictorian, 1979

    Society Basic Urologic Research - Merck Young Investigator Award, 1977

    Professional Activities

    Sidney Kimmel Comprehensive Cancer Center Advisory Council, 2004-present

    Advisory Board, Johns Hopkins Graduate Medical Education

    Budget Committee, Johns Hopkins Clinical Practice Association

    Executive Committee, Early Diagnostic Research Network, National Cancer Institute

    Prostate Cancer Advisory Board, American Cancer Society

    Infonet Editorial Board, American Cancer Society

    Departmental Evaluation & Management CPT Protocol Coordinator

    Program Committee, Mid-Atlantic Section of the American Urological Assoc., Inc.

    Panel Chairman, Early Detection of Prostate Cancer, National Comprehensive Cancer Network, 2000-2002

    Research Council for the American Urological Association, 2001-2003

    Alumni group, Alpha Omega Alpha, 2002

    Nominating Committee, Mid-Atlantic AUA, 1999

    Vice President, Phi Kappa Phi

  • Videos & Media +

    Videos

    Current Issues in Prostate Cancer: Johns Hopkins Medicine

    Prostate cancer detection and treatment remains an area of controversy. Expert guidance to help you negotiate whether or not to be tested and which management and treatment strategies are appropriate can be found at Johns Hopkins, as can the latest in research.

    Video Links

  • Events +
  • Contact & Locations +

    Locations

    Johns Hopkins Outpatient Center
    601 N. Caroline Street
    Baltimore, MD 21287
    Phone: 410-614-4876
    Appointment Phone: 410-955-6100
    Fax: 410-955-0833
    Location Map
    The Johns Hopkins Hospital
    600 N. Wolfe Street
    Hospital Main Entrance - Sheikh Zayed Tower
    Baltimore, MD 21287
    Phone: 410-614-4876
    Appointment Phone: 410-955-6100
    Fax: 410-955-0833
    Location Map

    Department/Division

    • Urology

Is This You? Edit Profile

 
 
 
 

© The Johns Hopkins University, The Johns Hopkins Hospital, and Johns Hopkins Health System. All rights reserved.

Privacy Policy and Disclaimer